Agilent Technologies Inc. has introduced the AriaMx System, the first instrument for real-time polymerase chain-reaction (PCR) that features easily-changeable optics cartridges for genotyping via high ...

With the Agilent Certified Pre-Owned refurbishment process, you can be confident that the Certified Pre-Owned AriaMx Real-time PCR system will provide you the same performance as a new instrument. The ...

Agilent Technologies Inc. today announced the launch of a real-time reverse transcription PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA.

The global PCR (Polymerase Chain Reaction) and realtime PCR testing market, having reached a valuation of nearly $10.1 billion in 2023, is anticipated to experience a robust compound annual growth ...

The two companies also announced that A has entered into another agreement with Applera to license certain Applera technology relating to A's PCR and real-time enzymes and kits.

The main aim of this project was to design and optimize a real-time quantitative PCR (qPCR) method that would enable precise quantification of the four major WT1 variants, and using this method to ...

Real-time polymerase chain reaction (PCR) is routinely used in laboratories to help identify pathogens, genotype infectious agents, and for cancer diagnostics.

Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection o ...

Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The CE-IVD mark is in ...